Singapore markets closed
Straits Times Index
3,297.55 -26.98 (-0.81%) S&P 500
5,431.60 -2.14 (-0.04%) Dow
38,589.16 -57.94 (-0.15%) Nasdaq
17,688.88 +21.28 (+0.12%) Bitcoin USD
66,625.38 +436.77 (+0.66%) CMC Crypto 200
1,385.35 -32.52 (-2.29%)
MRNA Jan 2025 155.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:06PM EDT. Market open.
| Previous close | 22.10 |
| Open | 17.70 |
| Bid | 18.05 |
| Ask | 18.40 |
| Strike | 155.00 |
| Expiry date | 2025-01-17 |
| Day's range | 17.65 - 17.75 |
| Contract range | N/A |
| Volume | |
| Open interest | 969 |
ZacksModerna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Data from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against COVID-19 when compared with its previously approved bivalent COVID-19 vaccine.
Simply Wall St.Moderna (NASDAQ:MRNA) shareholders are still up 857% over 5 years despite pulling back 6.1% in the past week
Long term investing can be life changing when you buy and hold the truly great businesses. And highest quality...
Yahoo FinanceModerna president: Company outlook 'stabilizing' thanks to new flu-COVID vaccine data
Moderna revealed its combination flu/COVID vaccine performed better than the two shots independently.
© 2024 Yahoo. All rights reserved.